Current issues in antiplatelet therapy for stroke prevention: the importance of stroke subtypes and differences between stroke and MI patients.

Journal of Neurology
H S Kirshner

Abstract

Ischaemic stroke, the most common type of stroke, is classified into three main subtypes: large-vessel disease, lacunar or small-vessel disease, and cardioembolic; two further subtypes include a determined aetiology of "other" and cryptogenic. Although a substantial amount of literature exists concerning current guidelines for the secondary prevention of ischaemic stroke, treatment strategies for stroke subtypes as well as the reasons why these subtypes are significant have yet to be clearly defined. Furthermore, treatment strategies for secondary prevention of ischaemic stroke differ between patients who have suffered a previous stroke and those who have suffered a myocardial infarction. Antiplatelet therapies offer treatment that is as efficacious as warfarin, but with less severe bleeding. This review examines the importance of the different subtypes of stroke as well as differentiating between treating a heart patient and a stroke patient for secondary stroke prevention, including the advantages of using antiplatelet therapy over anticoagulants.

References

Nov 6, 1998·Lancet·C P Warlow
Dec 3, 1999·Stroke; a Journal of Cerebral Circulation·G W PettyD O Wiebers
May 8, 2000·Stroke; a Journal of Cerebral Circulation·G W PettyD O Wiebers
Feb 15, 2001·JAMA : the Journal of the American Medical Association·H IsoW C Willett
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Nov 3, 2001·Stroke; a Journal of Cerebral Circulation·A J GrauH C Diener
Dec 26, 2001·The New England Journal of Medicine·F Catella-LawsonG A FitzGerald
Jan 17, 2002·The New England Journal of Medicine·J P MohrUNKNOWN Warfarin-Aspirin Recurrent Stroke Study Group
Jun 5, 2002·Circulation·Shunichi HommaUNKNOWN PFO in Cryptogenic Stroke Study (PICSS) Investigators
Sep 18, 2002·JAMA : the Journal of the American Medical Association·Sharon E StrausFinlay A McAlister
Dec 27, 2002·JAMA : the Journal of the American Medical Association·Ka HeAlberto Ascherio
Mar 8, 2003·Stroke; a Journal of Cerebral Circulation·Salah-Eddine MegherbiUNKNOWN European BIOMED Study of Stroke Care Group
Mar 8, 2003·Stroke; a Journal of Cerebral Circulation·Nina VartiainenJari Koistinaho
May 17, 2003·Stroke; a Journal of Cerebral Circulation·Thomas HillenUNKNOWN South London Stroke Register
May 31, 2003·Stroke; a Journal of Cerebral Circulation·Seung-Han SukUNKNOWN Northern Manhattan Stroke Study
Nov 5, 2003·Annals of Neurology·Matthias EndresUlrich Laufs
May 1, 2004·Stroke; a Journal of Cerebral Circulation·Toshifumi MannamiUNKNOWN Japan Public Health Center-Based Prospective Study on Cancer and Cardiovascular Disease Group
May 18, 2004·Journal of the American College of Cardiology·John A Ambrose, Rajat S Barua
Aug 17, 2004·American Heart Journal·Deepak L BhattUNKNOWN Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance Executive Committee
Nov 5, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K MatzM Brainin
Mar 11, 2005·The New England Journal of Medicine·Marc S SabatineUNKNOWN CLARITY-TIMI 28 Investigators
Mar 16, 2005·Archives of Neurology·Sean RulandUNKNOWN African American Antiplatelet Stroke Prevention Study Investigators
Aug 16, 2005·Journal of the American College of Cardiology·Andrew L Frelinger, Alan D Michelson
Nov 8, 2005·Lancet·Z M ChenUNKNOWN COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group
Dec 3, 2005·The Journal of the American Board of Family Practice·Howard S KirshnerAlfred S Callahan
Feb 28, 2006·Journal of Cardiac Failure·Patrick PullicinoUNKNOWN WARCEF Investigators
Mar 15, 2006·The New England Journal of Medicine·Deepak L BhattUNKNOWN CHARISMA Investigators
Jun 27, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T TruelsenG Boysen
Aug 26, 2006·Stroke; a Journal of Cerebral Circulation·Tetsuya OhiraAaron R Folsom

❮ Previous
Next ❯

Citations

Apr 5, 2011·Current Treatment Options in Cardiovascular Medicine·Jaime Gállego Culleré, María Elena Erro Aguirre

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.